CRSP vs KR · rev $37.3M vs P/E 19, rev $147.12B
Crispr Therapeutics AG (CRSP) versus Kroger Company (KR) — a side-by-side from cached financials, not a winner call.
Crispr Therapeutics AG (CRSP) is a biotechnology company listed on US.
Kroger Company (KR) is a grocery stores company listed on US.
Latest reported CRSP revenue for 2024-12-31 was $37.3M. Net income was -$366.3M. Revenue was down 89.9% from 2023-12-31 to 2024-12-31. CRSP currently screens at market cap $5.42B.
Latest reported KR revenue for 2025-02-01 was $147.12B. Net income was $2.67B. KR currently screens at market cap $46.17B and trailing P/E 19.0.
CRSP currently screens at market cap $5.42B. KR currently screens at market cap $46.17B and trailing P/E 19.0.
Not investment advice. Open the CRSP and KR stock pages for the full models.
Not investment advice.